Himuka AM Pharma / Himuka AM Australia
The startup develops a bioactive peptide aimed at promoting mucosal healing and achieving clinical remission in patients. By focusing on enhancing adrenomedullin, the company addresses the unmet medical needs associated with mucosal damage and related conditions.
- Biotechnology
Updated 21 months ago
Funding
Raised to date
$11.2MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops a bioactive peptide aimed at promoting mucosal healing and achieving clinical remission in patients. By focusing on enhancing adrenomedullin, the company addresses the unmet medical needs associated with mucosal damage and related conditions.